PLoS ONE 2015-01-01

Analyses of the pathways involved in early- and late-phase induction of IFN-beta during C. muridarum infection of oviduct epithelial cells.

Sishun Hu, Kristen L Hosey, Wilbert A Derbigny

Index: PLoS ONE 10(3) , e0119235, (2015)

Full Text: HTML

Abstract

We previously reported that the IFN-β secreted by Chlamydia muridarum-infected murine oviduct epithelial cells (OE cells) was mostly dependent on the TLR3 signaling pathway. To further characterize the mechanisms of IFN-β synthesis during Chlamydia infection of OE cells in vitro, we utilized specific inhibitory drugs to clarify the roles of IRF3 and NF-κB on both early- and late-phase C. muridarum infections. Our results showed that the pathways involved in the early-phase of IFN-β production were distinct from that in the late-phase of IFN-β production. Disruption of IRF3 activation using an inhibitor of TBK-1 at early-phase Chlamydia infection had a significant impact on the overall synthesis of IFN-β; however, disruption of IRF3 activation at late times during infection had no effect. Interestingly, inhibition of NF-κB early during Chlamydia infection also had a negative effect on IFN-β production; however, its impact was not significant. Our data show that the transcription factor IRF7 was induced late during Chlamydia infection, which is indicative of a positive feedback mechanism of IFN-β synthesis late during infection. In contrast, IRF7 appears to play little or no role in the early synthesis of IFN-β during Chlamydia infection. Finally, we demonstrate that antibiotics that target chlamydial DNA replication are much more effective at reducing IFN-β synthesis during infection versus antibiotics that target chlamydial transcription. These results provide evidence that early- and late-phase IFN-β production have distinct signaling pathways in Chlamydia-infected OE cells, and suggest that Chlamydia DNA replication might provide a link to the currently unknown chlamydial PAMP for TLR3.

Related Compounds

Structure Name/CAS No. Articles
sodium chloride Structure sodium chloride
CAS:7647-14-5
Ofloxacin Structure Ofloxacin
CAS:82419-36-1
sodium dodecyl sulfate Structure sodium dodecyl sulfate
CAS:151-21-3
Rifampicin Structure Rifampicin
CAS:13292-46-1
L-Alanyl-L-Glutamine Structure L-Alanyl-L-Glutamine
CAS:39537-23-0
SODIUM CHLORIDE-35 CL Structure SODIUM CHLORIDE-35 CL
CAS:20510-55-8